Intergroup, Italian Melanoma. 2025. “35 | Real-World Outcomes of Targeted Therapy in Stage IV Melanoma After Relapse on Adjuvant Dabrafenib and Trametinib: Insights from a Single-Center Cohort: Rossella Villani, Chiara Bungaro, Anna Cecere, Ileana De Roma, Sabino Strippoli, Michele Guida | Rare Tumors and Melanoma Unit, IRCCS Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy”. Dermatology Reports, December. https://doi.org/10.4081/dr.2025.10777.